INVITRO ANTITUMOR EFFECT OF LYMPHOID-CELLS FROM CORYNEBACTERIUM-PARVUM-TREATED MICE - EFFECT OF ROUTE OF C-PARVUM ADMINISTRATION

被引：11

作者：

GHAFFAR, A ^{[1
]}

CULLEN, RT ^{[1
]}

机构：

[1] UNIV EDINBURGH,SCH MED,DEPT SURG,EDINBURGH EH10 5HF,SCOTLAND

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1977年 / 58卷 / 03期

关键词：

D O I：

10.1093/jnci/58.3.717

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：717 / 720

页数：4

共 17 条

[1]

BOMFORD R, 1974, INT J CANCER, V14, P226

[2] ACTIVE SPECIFIC IMMUNOTHERAPY OF MOUSE METHYLCHOLANTHRENE INDUCED TUMORS WITH CORYNEBACTERIUM-PARVUM AND IRRADIATED TUMOR-CELLS [J].

BOMFORD, R .

BRITISH JOURNAL OF CANCER, 1975, 32 (05) :551-557

[3] FURTHER ANALYSIS OF ANTITUMOR EFFECT INVITRO OF PERITONEAL EXUDATE CELLS FROM MICE TREATED WITH CORYNEBACTERIUM-PARVUM [J].

GHAFFAR, A ;

CULLEN, RT ;

WOODRUFF, MF .

BRITISH JOURNAL OF CANCER, 1975, 31 (01) :15-24

[4]

GHAFFAR A, 1976, J RETICULOENDOTH SOC, V20, P349

[5] ANTITUMOR EFFECT INVITRO OF LYMPHOCYTES AND MACROPHAGES FROM MICE TREATED WITH CORYNEBACTERIUM-PARVUM [J].

GHAFFAR, A ;

CULLEN, RT ;

DUNBAR, N ;

WOODRUFF, MF .

BRITISH JOURNAL OF CANCER, 1974, 29 (03) :199-205

[6]

LIKHITE VV, 1974, CANCER RES, V34, P341

[7] IMMUNOPROPHYLAXIS AND IMMUNOTHERAPY FOR A MURINE FIBROSARCOMA WITH C-GRANULOSUM AND C-PARVUM [J].

MILAS, L ;

GUTTERMAN, JU ;

BASIC, I ;

HUNTER, N ;

MAVLIGIT, GM ;

HERSH, EM ;

WITHERS, HR .

INTERNATIONAL JOURNAL OF CANCER, 1974, 14 (04) :493-503

[8] INVITRO INHIBITION OF TUMOR-CELL GROWTH AND DNA-SYNTHESIS BY PERITONEAL AND LUNG MACROPHAGES FROM MICE INJECTED WITH CORYNEBACTERIUM-PARVUM [J].

OLIVOTTO, M ;

BOMFORD, R .

INTERNATIONAL JOURNAL OF CANCER, 1974, 13 (04) :478-488

[9] CORYNEBACTERIUM-PARVUM AS A THERAPEUTIC ANTITUMOR AGENT IN MICE .2. LOCAL INJECTION [J].

SCOTT, MT .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) :861-865

[10] CORYNEBACTERIUM-PARVUM AS A THERAPEUTIC ANTITUMOR AGENT IN MICE .1. SYSTEMIC EFFECTS FROM INTRAVENOUS-INJECTION [J].

SCOTT, MT .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) :855-860

← 1 2 →